Grindr Q3: Strong Earnings Beat Expectations Amid Take-Private Talks
Grindr beats Q3 estimates with 30% revenue growth and 17% increase in paying users, maintaining strong performance as majority investors propose $3.5B take-private deal.
Grindr beats Q3 estimates with 30% revenue growth and 17% increase in paying users, maintaining strong performance as majority investors propose $3.5B take-private deal.
Novo Nordisk is set to sell its popular weight-loss drugs like Wegovy on Hims & Hers platform soon, surprising many after a recent lawsuit over copycat versions. This could boost access and help both companies in the competitive obesity market.
S&P Dow Jones announces March 2026 quarterly rebalance. Vertiv (VRT), Lumentum (LITE), Coherent (COHR), and EchoStar (SATS) join the S&P 500.
Dr. Vinay Prasad, head of the FDA's vaccines and biologics division, is stepping down at the end of April after a controversial year overseeing approvals for vaccines, gene therapies, and biotech products.